XML 92 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Quarterly Data (Unaudited) (Tables)
 12 Months Ended
Apr. 30, 2022
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information
Selected quarterly financial data for fiscal years 2022 and 2021 were as follows:
$ in thousands, except per share amountsFirst
Quarter		Second
Quarter		Third
Quarter		Fourth
Quarter
Fiscal Year 2022
Net sales$39,493 $39,031 $40,633 $49,715 
Gross profit5,674 3,597 5,622 9,327 
Net loss(1,307)(3,082)(1,286)(328)
Less: net earnings attributable to the non-controlling interest38 18 33 34 
Net loss attributable to Kewaunee Scientific Corporation(1,345)(3,100)(1,319)(362)
Net loss per share attributable to Kewaunee Scientific Corporation
Basic(0.48)(1.11)(0.47)(0.13)
Diluted(0.48)(1.11)(0.47)(0.13)
Fiscal Year 2021
Net sales$36,423 $39,000 $33,339 $38,707 
Gross profit5,881 6,395 5,654 6,063 
Net (loss) earnings(608)(165)95 (2,929)
Less: net (loss) earnings attributable to the non-controlling interest(10)15 14 46 
Net (loss) earnings attributable to Kewaunee Scientific Corporation(598)(180)81 (2,975)
Net (loss) earnings per share attributable to Kewaunee Scientific Corporation
Basic(0.22)(0.07)0.03 (1.08)
Diluted(0.22)(0.07)0.03 (1.08)